Watch the summary video
Investment NSW Case Study - Going Global Export Program - Southern Star Research
Southern Star took participated in the Going Global Export Program Health to USA 2023.
Helping biotech companies bring treatments to market
Southern Star Research is a privately owned Australian Contract Research Organisation (CRO) based in NSW. It helps speed up the launch of new therapies by supporting clients from the early stages of clinical development. This includes clinical trials, project management and regulatory approvals. The company also provides research expertise for biotech, pharmaceutical and medical device companies.
Export support through Going Global
In 2023, Southern Star Research joined the Going Global Export Program: Health to USA. Through this program, and as a delegate to BIO San Diego 2024, the company received:
- introductions to potential US partners
- tailored business matching and meeting support
- help with profiling and pitching to international buyers
- invitations to NSW-led networking events.
These activities led to strong business leads and export sales in the competitive US health market.
Sharing success with peers
Southern Star Research CEO David Lloyd spoke at the 2023 and 2024 Health to USA events as a keynote speaker.
He shared insights with fellow NSW exporters on how to:
- get the most from export programs
- prepare for global market entry
- build long-term international partnerships.